Elevated serum levels of pigment epithelium-derived factor in the metabolic syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 6, 2006, Pages 2447-2450

  Yamagishi, Sho Ichi ^a   Adachi, Hisashi ^a   Abe, Akio ^b   Yashiro, Takako ^b   Enomoto, Mika ^a   Furuki, Kumiko ^a   Hino, Asuka ^a   Jinnouchi, Yuko ^a   Takenaka, Katsuhiko ^a   Matsui, Takanori ^a   Nakamura, Kazuo ^a   Imaizumi, Tsutomu ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SRL INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PIGMENT EPITHELIUM DERIVED FACTOR; URIC ACID;

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; CORONARY RISK; FEMALE; HUMAN; MALE; METABOLIC SYNDROME X; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; RISK ASSESSMENT; RISK FACTOR; WAIST CIRCUMFERENCE;

AGED; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EYE PROTEINS; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NERVE GROWTH FACTORS; REGRESSION ANALYSIS; SERPINS;

EID: 33646189532     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-2654     Document Type: Article

References (17)

1. Tombran-Tink J, Chader CG, Johnson LV 1991 PEDF: pigment epithelium-derived factor with potent neuronal differentiative activity. Exp Eye Res 53:411-414
2. Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu H, Benedict W, Bouck NP 1999 Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 285:245-248
3. Duh EJ, Yang HS, Suzuma I, Miyagi M, Youngman E, Mori K, Katai M, Yan L, Suzuma K, West K, Davarya S, Tong P, Gehlbach P, Pearlman J, Crabb JW, Aiello LP, Campochiaro PA, Zack DJ 2002 Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth. Invest Ophthalmol Vis Sci 43:821-829
4. Spranger J, Osterhoff M, Reimann M, Mohlig M, Ristow M, Francis MK, Cristofalo V, Hammes HP, Smith G, Boulton M, Pfeiffer AF 2002 Loss of antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease. Diabetes 50:2641-2645
5. Yamagishi S, Inagaki Y, Nakamura K, Abe R, Shimizu T, Yoshimura A, Imaizumi T 2004 Pigment epithelium-derived factor inhibits TNF-α-induced interleukin-6 expression in endothelial cells by suppressing NADPH oxidase-mediated reactive oxygen species generation. J Mol Cell Cardiol 37:497-506
6. Inagaki Y, Yamagishi S, Okamoto T, Takeuchi M, Amano S 2003 Pigment epithelium-derived factor prevents advanced glycation end products-induced monocyte chemoattractant protein-1 production in microvascular endothelial cells by suppressing intracellular reactive oxygen species generation. Diabetologia 46:284-287
7. Yamagishi S, Nakamura K, Ueda S, Kato S, Imaizumi T 2005 Pigment epithelium-derived factor (PEDF) blocks angiotensin II signaling in endothelial cells via suppression of NADPH oxidase: a novel anti-oxidative mechanism of PEDF. Cell Tissue Res 320:437-445
8. McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW 2004 Renal insufficiency and heart failure. Prognostic and therapeutic implications from a prospective cohort study. Circulation 109:1004-1009
9. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) 2002 Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): final report. Circulation 106:3143-3421
10. Marchesini G, Forlani G, Cerrelli F, Manini R, Natale S, Baraldi L, Ermini G, Savorani G, Zocchi D, Melchionda N 2004 WHO and ATPIII proposals for the definition of the metabolic syndrome in patients with type 2 diabetes. Diabet Med 21:383-387
11. Grundy SM, Cleeman CJ, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gorton DJ, Krauss RM, Savage PJ, Smith SC, Spertus JA, Costa F 2005 Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 112:2735-2752
12. Tsunoda S, Kamide K, Minami J, Kawano Y 2002 Decreases in serum uric acid by amelioration of insulin resistance in overweight hypertensive patients: effect of a low-energy diet and an insulin-sensitizing agent. Am J Hypertens 15:697-701
13. Costacou T, Zgibor JC, Evans RW, Otvos J, Lopes-Virella MF, Tracy RP, Orchard TJ 2005 The prospective association between adiponectin and coronary artery disease among individuals with type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia 48:41-48
14. Tombran-Tink J, Mazuruk K, Rodriguez IR, Chung D, Linker T, Englander E, Chader GJ 1996 Organization, evolutionary conservation, expression and unusual Alu density of the human gene for pigment epithelium-derived factor, a unique neurotrophic serpin. Mol Vis 2:11
15. Ponsuksili S, Murani E, Schellander K, Schwerin M, Wimmers K 2005 Identification of functional candidate genes for body composition by expression analyses and evidencing impact by association analysis and mapping. Biochim Biophys Acta 1730:31-40
16. Kratchmarova I, Kalume DE, Blagoev B, Scherer PE, Podtelejnikov AV, Molina H, Bickel PE, Andersen JS, Fernandez MM, Bunkenborg J, Roepstorff P, Kristiansen K, Lodish HF, Mann M, Pandey A 2002 A proteomic approach for identification of secreted proteins during the differentiation of 3T3-L1 preadipocytes to adipocytes. Mol Cell Proteomics 1:213-222
17. Matsuzawa Y 2006 Therapy insight: adipocytokines in metabolic syndrome and related cardiovascular disease. Nat Clin Pract Cardiovasc Med 3:35-42